Micafungin and Tpn drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micafungin (micafungin sodium) and Tpn (niacinamide; pyridoxine hydrochloride; tyrosine). Common drug interactions include pneumonia among females and cardiac failure among males.

The phase IV clinical study analyzes what interactions people have when they take Micafungin and Tpn. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Micafungin?

Micafungin has active ingredients of micafungin sodium. eHealthMe is studying from 6,562 Micafungin users. Check the latest studies of Micafungin.

What is Tpn?

Tpn has active ingredients of niacinamide; pyridoxine hydrochloride; tyrosine. eHealthMe is studying from 1,581 Tpn users. Check the latest studies of Tpn.

On Jul, 15, 2026

39 people who take Micafungin and Tpn together, and have interactions are studied.

What are the common drug interactions of Micafungin and Tpn, by gender? *:

female:

Pneumonia
Pulmonary toxicity (side effects on the lungs)
Sinusitis (inflammation of sinus)
Weight decreased
Hypotension (abnormally low blood pressure)
Abdominal abscess (collection of pus in abdomen)
Abdominal pain
Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
Appetite disorder (abnormal eating habits)
Asthenia (weakness)

male:

Cardiac failure
Sepsis (a severe blood infection that can lead to organ failure and death)
C-reactive protein increased
Cystitis (inflammation of the wall of the bladder)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Decreased appetite
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Enterocutaneous fistula
Hospitalisation

What are the common drug interactions of Micafungin and Tpn, by age (0-1 to 60+)? *:

0-1:

Hepatitis (inflammation of the liver)

2-9:

Renal failure (kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)

10-19:

Periorbital oedema (swelling around the eyes)
Peripheral swelling
Pulmonary oedema (fluid accumulation in the lungs)
Pyrexia (fever)
Renal impairment (severely reduced kidney function)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Sedation
Serum ferritin increased
Somnolence (a state of near-sleep, a strong desire for sleep)
Swelling

20-29:

Anaemia (lack of blood)
Atelectasis (partial or complete collapse of the lung)
Blood bilirubin increased
Nausea (feeling of having an urge to vomit)
Pleural effusion (water on the lungs)
Pyrexia (fever)
Renal haemorrhage (bleeding from kidney)
Renal impairment (severely reduced kidney function)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Vomiting

30-39:

Anaemia (lack of blood)
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Device dislocation
Haemodynamic instability (disturbances in the blood movement in our body)
Haemoglobin decreased
Klebsiella infection
Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
Respiratory failure (inadequate gas exchange by the respiratory system)
Thrombocytopenia (decrease of platelets in blood)

40-49:

Small intestinal obstruction (blockage in small intestine)
C-reactive protein increased
Enterocutaneous fistula
Staphylococcal bacteraemia (a bacterial infection of blood)

50-59:

Acute respiratory distress syndrome
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Alanine aminotransferase increased
Aphasia (damage to the parts of the brain that control language)
Aspartate aminotransferase increased
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Hypotension (abnormally low blood pressure)

60+:

Cardiac failure
Sepsis (a severe blood infection that can lead to organ failure and death)
Dyspnoea (difficult or laboured respiration)
Fall
Fatigue (feeling of tiredness)
Haematoma (collection of blood outside the blood vessels)
Insomnia (sleeplessness)
Localised infection (infection at the single location)
Malaise (a feeling of general discomfort or uneasiness)
Pain

What are the existing conditions these people have? *

Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 10 people, 25.64%
Flatulence (flatus expelled through the anus): 10 people, 25.64%
Nausea (feeling of having an urge to vomit): 10 people, 25.64%
Pain: 10 people, 25.64%
Pneumonia: 8 people, 20.51%
Hypokalemia (low potassium): 8 people, 20.51%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 7 people, 17.95%
Insomnia (sleeplessness): 7 people, 17.95%
Itching: 7 people, 17.95%
High Blood Pressure: 7 people, 17.95%

* Approximation only. Some reports may have incomplete information.

Do you take Micafungin and Tpn?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously